🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Post Market Clinical Follow up study to fulfil the post mar...
Status
Terminated
Location
Multiple Locations
Start Date
2011-04-28
Trial ID
NCT04079114
Treatments Being Tested
Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized ...
Status
Not Yet Recruiting
Location
Sohag University hospitals
Start Date
2024-08-15
Trial ID
NCT06562049
Treatments Being Tested
The investigators aim to evaluate the non-inferiority of administering toci...
Status
Not Yet Recruiting
Location
CHU de Nice
Start Date
2026-06-01
Trial ID
NCT07582185
Treatments Being Tested
This study aims at elucidating the mechanism of action of ianalumab in sali...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-07-27
Trial ID
NCT05124925
Treatments Being Tested
Azathioprine (AZA) and its metabolite 6-mercaptopurine (6-MP) were develope...
Status
Withdrawn
Location
Shaare Zedek
Start Date
2015-03
Trial ID
NCT02281799
Treatments Being Tested
National, prospective, multicentre observational study designed for eligibl...
Status
Completed
Location
Hopitaux Universitaires de Strasbourg - Hopital de Hautepierre
Start Date
2016-10-19
Trial ID
NCT02925338
Treatments Being Tested
Inflammatory joint diseases (IJD) are autoimmune diseases with common sympt...
Status
Completed
Location
Diakonhjemmet Hospital
Start Date
2021-08-09
Trial ID
NCT04922840
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety, tolerability...
Status
Terminated
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00831649
Treatments Being Tested
This study is to assess the safety, tolerability, and pharmacokinetics (PK)...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02176876
Treatments Being Tested
To evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-27
Trial ID
NCT07737743